Adapalene; Benzoyl Peroxide Patent Expiration

Adapalene; Benzoyl Peroxide is Used for treating acne. It was first introduced by Galderma Laboratories Lp in its drug Epiduo on Dec 8, 2008. Another drug containing Adapalene; Benzoyl Peroxide is Epiduo Forte. 10 different companies have introduced drugs containing Adapalene; Benzoyl Peroxide.


Adapalene; Benzoyl Peroxide Patents

Given below is the list of patents protecting Adapalene; Benzoyl Peroxide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Epiduo US8071644 Combinations of adapalene and benzoyl peroxide for treating acne lesions Jul 18, 2027 Galderma Labs Lp
Epiduo US8080537 Combinations of adapalene and benzoyl peroxide for treating acne lesions Jul 18, 2027 Galderma Labs Lp
Epiduo US8129362 Combination/association of adapalene and benzoyl peroxide for treating acne lesions Jul 18, 2027 Galderma Labs Lp
Epiduo US8445543 Combinations of adapalene and benzoyl peroxide for treating acne lesions Jul 12, 2027 Galderma Labs Lp
Epiduo US7820186 Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt Nov 23, 2025 Galderma Labs Lp
Epiduo US7964202 Method for treatment of common acne Sep 01, 2024

(Expired)

Galderma Labs Lp
Epiduo Forte US8703820 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar 12, 2023

(Expired)

Galderma Labs
Epiduo Forte US8729127 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar 12, 2023

(Expired)

Galderma Labs
Epiduo Forte US9381179 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar 12, 2023

(Expired)

Galderma Labs
Epiduo Forte US9387187 Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders Mar 12, 2023

(Expired)

Galderma Labs
Epiduo US8105618 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide Dec 23, 2022

(Expired)

Galderma Labs Lp
Epiduo US8241649 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide Dec 23, 2022

(Expired)

Galderma Labs Lp
Epiduo US8809305 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris Dec 23, 2022

(Expired)

Galderma Labs Lp
Epiduo US8936800 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt Dec 23, 2022

(Expired)

Galderma Labs Lp
Epiduo Forte US8445543 Combinations of adapalene and benzoyl peroxide for treating acne lesions Dec 23, 2022

(Expired)

Galderma Labs
Epiduo Forte US8785420 Combination/association of adapalene and benzoyl peroxide for treating acne lesions Dec 23, 2022

(Expired)

Galderma Labs
Epiduo Forte US8809305 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris Dec 23, 2022

(Expired)

Galderma Labs
Epiduo Forte US8909305 Method and system for activating an application on a mobile device Dec 23, 2022

(Expired)

Galderma Labs
Epiduo Forte US8936800 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt Dec 23, 2022

(Expired)

Galderma Labs
Epiduo Forte US9814690 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt Dec 23, 2022

(Expired)

Galderma Labs



Adapalene; Benzoyl Peroxide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Adapalene; Benzoyl Peroxide Generic API Manufacturers

Several generic applications have been filed for Adapalene; Benzoyl Peroxide. The first generic version for Adapalene; Benzoyl Peroxide was by Actavis Mid Atlantic Llc and was approved on Sep 30, 2015. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Aug 4, 2022.

Given below is the list of companies who have filed for Adapalene; Benzoyl Peroxide generic, along with the locations of their manufacturing plants worldwide.